150 related articles for article (PubMed ID: 26316204)
1. Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis.
Liu R; Martin TA; Jordan NJ; Ruge F; Ye L; Jiang WG
Int J Oncol; 2015 Oct; 47(4):1429-39. PubMed ID: 26316204
[TBL] [Abstract][Full Text] [Related]
2. The tumour suppressive role of metastasis suppressor-1, MTSS1, in human kidney cancer, a possible connection with the SHH pathway.
Du P; Ye L; Li H; Yang Y; Jiang WG
J Exp Ther Oncol; 2012; 10(2):91-9. PubMed ID: 23350348
[TBL] [Abstract][Full Text] [Related]
3. Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.
Du P; Ye L; Ruge F; Yang Y; Jiang WG
Anticancer Res; 2011 Oct; 31(10):3205-12. PubMed ID: 21965727
[TBL] [Abstract][Full Text] [Related]
4. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.
Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S
Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499
[TBL] [Abstract][Full Text] [Related]
5. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.
Parr C; Jiang WG
Eur J Cancer; 2009 Jun; 45(9):1673-83. PubMed ID: 19328678
[TBL] [Abstract][Full Text] [Related]
6. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of microtubule-associated protein 1 light chain 3B via small-interfering RNA or 3-methyladenine impairs hypoxia-induced HO8910PM and HO8910 epithelial ovarian cancer cell migration and invasion and is associated with RhoA and alterations of the actin cytoskeleton.
Tang Z; Zhang N; Di W; Li W
Oncol Rep; 2015 Mar; 33(3):1411-7. PubMed ID: 25607473
[TBL] [Abstract][Full Text] [Related]
8. The impact of Metastasis Suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance.
Xie F; Ye L; Chen J; Wu N; Zhang Z; Yang Y; Zhang L; Jiang WG
J Transl Med; 2011 Jun; 9():95. PubMed ID: 21696600
[TBL] [Abstract][Full Text] [Related]
9. Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer.
Liu R; Martin TA; Jordan NJ; Ruge F; Ye L; Jiang WG
Int J Oncol; 2016 Jun; 48(6):2488-96. PubMed ID: 27035883
[TBL] [Abstract][Full Text] [Related]
10. MTSS1 suppresses cell migration and invasion by targeting CTTN in glioblastoma.
Zhang S; Qi Q
J Neurooncol; 2015 Feb; 121(3):425-31. PubMed ID: 25385572
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑139 suppressed tumor cell proliferation, migration and invasion by directly targeting HDGF in epithelial ovarian cancer.
Liu J; Jin S; Wang R
Mol Med Rep; 2017 Sep; 16(3):3379-3386. PubMed ID: 28713954
[TBL] [Abstract][Full Text] [Related]
12. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
Du P; Wang S; Tang X; An C; Yang Y; Jiang WG
Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 regulates metastatic capabilities and chemotherapy sensitivity in epithelial ovarian carcinoma via NF-κB pathway.
Lu H; Liu Y; Wang D; Wang L; Zhou H; Xu G; Xie L; Wu M; Lin Z; Yu Y; Li G
Tumour Biol; 2016 Aug; 37(8):11469-77. PubMed ID: 27012551
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
16. High GMFG expression correlates with poor prognosis and promotes cell migration and invasion in epithelial ovarian cancer.
Zuo P; Ma Y; Huang Y; Ye F; Wang P; Wang X; Zhou C; Lu W; Kong B; Xie X
Gynecol Oncol; 2014 Mar; 132(3):745-51. PubMed ID: 24486602
[TBL] [Abstract][Full Text] [Related]
17. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.
Lin M; Xia B; Qin L; Chen H; Lou G
DNA Cell Biol; 2018 May; 37(5):491-500. PubMed ID: 29485916
[TBL] [Abstract][Full Text] [Related]
18. Up-Regulation of miR-204 Enhances Anoikis Sensitivity in Epithelial Ovarian Cancer Cell Line Via Brain-Derived Neurotrophic Factor Pathway In Vitro.
Yan H; Wu W; Ge H; Li P; Wang Z
Int J Gynecol Cancer; 2015 Jul; 25(6):944-52. PubMed ID: 25962115
[TBL] [Abstract][Full Text] [Related]
19. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.
Zhang S; Lin QD; DI W
Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
